May occur for MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease patients when tapering to a lower dose of steroidsA type of medication typically given intraveneously or orally. For myelin oligodendrocyte glycoprotein antibody disease (MOGAD) it is used as an immunosuppressant and anti-inflammatory to reduce disease activity and inflammation. In adults, it is sometimes used in high doses for acute attacks. In some adult patients, it may be used for 1-2 months after an acute attack to avoid a rapid onset of relapse. Higher doses (>10mg/day) are not recommended for an extended period of time but lower doses (<=10mg/day) may be used in some patients longer term. In children, it may be used after treatment of an acute attack, but it is not recommended long-term due to the profound effects of chronic steroids on a child's health. Use of oral prednisone as a maintenance therapy in relapsing pediatric MOGAD patients is discouraged due to side effects in developing children, and other therapies such as monthly immune globulin are suggested. (To understand relapsing during steroid tapering, see Steroid Dependency) causing recurrance of symptoms and may cause a relapseWhen you present to your doctor or hospital with new or worsening central nervous system symptoms. Generally, if your symptoms gradually worsen over 24-48 hours, there is heightened concern of a relapse. (Also referred to as a flare by the myelin oligodendrocyte glycoproten antibody disease (MOGAD) community). of new disease activity.
Steroid Dependency
Related Posts
Caring for a Child with MOGAD: Expert Q&A | The MOG Project
By Simon Wesson, UK Regional Delegate for The MOGA type of protein involved in cell adhesion. Present throughout myelin sheaths. Project · 7-minute read Caring for a child with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)Often referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease brings
Isabel’s Fight for a MOGAD Diagnosis | The MOG Project
By Peter Fontanez, Isabel’s dad · 12-minute read In 2014, 5-year-old Isabel Fontanez went to a Father-Daughter Dance with her dad. Two days later, she
Patrick’s Story: A Teen Living with MOGAD | The MOG Project
By Patrick, The MOGA type of protein involved in cell adhesion. Present throughout myelin sheaths. Project Youth Champion™ Patrick is 16, a high school junior and one of The MOGA type of protein involved in cell adhesion. Present throughout myelin sheaths. Project’s Youth Champions™. He was diagnosed
